Sientra, Inc. Provides Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
January 10, 2022 at 08:00 am
Share
Sientra, Inc. provided preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021. Preliminary, unaudited revenue from continuing operations for the fourth quarter 2021 is expected to be in the range of $22.0 million to $23.0 million, representing growth of 23% to 29% over the fourth quarter of 2020.
Preliminary, unaudited revenue from continuing operations for the full year 2021 is expected to be in the range of $80.0 million to $81.0 million, representing growth of 46% to 47% compared to the full year 2020.
Project Sage Oldco Inc., formerly Sientra, Inc., is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
PROJECT SAGE OLDCO, INC. 
